These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11995656)

  • 1. Intensive insulin treatment reduced mortality and morbidity in critically ill patients.
    Binnekade JM
    Evid Based Nurs; 2002 Apr; 5(2):53. PubMed ID: 11995656
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?
    Siroen MP; van Leeuwen PA; Nijveldt RJ; Teerlink T; Wouters PJ; Van den Berghe G
    Crit Care Med; 2005 Mar; 33(3):504-10. PubMed ID: 15753739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive insulin therapy for critically ill patients.
    Lewis KS; Kane-Gill SL; Bobek MB; Dasta JF
    Ann Pharmacother; 2004; 38(7-8):1243-51. PubMed ID: 15187219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A literature review of intensive insulin therapy and mortality in critically ill patients.
    Chen L
    Clin Nurse Spec; 2010; 24(2):80-6. PubMed ID: 20168143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus recommendations for the management of hyperglycaemia in critically ill patients in the Indian setting.
    Mukherjee JJ; Chatterjee PS; Saikia M; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):16-25. PubMed ID: 25668933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive insulin treatment.
    Merz TM; Finfer S
    Minerva Anestesiol; 2009 Dec; 75(12):703-9. PubMed ID: 19940823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review.
    Langley J; Adams G
    Diabetes Metab Res Rev; 2007 Mar; 23(3):184-92. PubMed ID: 17089369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glycaemia control in critically ill patients is justified and effective].
    Rybka J
    Vnitr Lek; 2010 Sep; 56(9 Suppl):977-87. PubMed ID: 21137171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indication and practical use of intensive insulin therapy in the critically ill.
    Mebis L; Gunst J; Langouche L; Vanhorebeek I; Van den Berghe G
    Curr Opin Crit Care; 2007 Aug; 13(4):392-8. PubMed ID: 17599008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin therapy and acute kidney injury in critically ill patients a systematic review.
    Thomas G; Rojas MC; Epstein SK; Balk EM; Liangos O; Jaber BL
    Nephrol Dial Transplant; 2007 Oct; 22(10):2849-55. PubMed ID: 17604310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stress hyperglycemia and its control with insulin in critically ill patients: current evidence].
    Manzanares W; Aramendi I
    Med Intensiva; 2010 May; 34(4):273-81. PubMed ID: 19944490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of the month. Toxicity of hyperglycemia in intensive care and beneficial effects of optimized insulin therapy].
    Scheen AJ
    Rev Med Liege; 2001 Dec; 56(12):859-61. PubMed ID: 11820041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular aspects of insulin therapy in critically ill patients.
    Andreelli F; Jacquier D; Troy S
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):124-30. PubMed ID: 16477177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive insulin therapy reduced mortality and morbidity in critically ill patients.
    Hurley DL; McMahon MM
    ACP J Club; 2002; 136(3):81. PubMed ID: 11985422
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperglycemia in critically ill patients.
    Knieriem M; Otto CM; Macintire D
    Compend Contin Educ Vet; 2007 Jun; 29(6):360-2, 364-72; quiz 372. PubMed ID: 17724990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein turnover, lipolysis, and endogenous hormonal secretion in critically ill children.
    Cogo PE; Carnielli VP; Rosso F; Cesarone A; Giordano G; Faggian D; Plebani M; Barreca A; Zacchello F
    Crit Care Med; 2002 Jan; 30(1):65-70. PubMed ID: 11902289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of haloperidol prophylaxis in critically ill patients with a high risk of delirium: a systematic review.
    Santos E; Cardoso D; Neves H; Cunha M; Rodrigues M; Apóstolo J
    JBI Database System Rev Implement Rep; 2017 May; 15(5):1440-1472. PubMed ID: 28498176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients.
    Van den Berghe G; Wouters PJ; Kesteloot K; Hilleman DE
    Crit Care Med; 2006 Mar; 34(3):612-6. PubMed ID: 16521256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients.
    Vanhorebeek I; De Vos R; Mesotten D; Wouters PJ; De Wolf-Peeters C; Van den Berghe G
    Lancet; 2005 Jan 1-7; 365(9453):53-9. PubMed ID: 15639679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
    Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
    Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.